Press release
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
Bone Metastasis Pipeline
Explore the comprehensive insights by DelveInsight and stay ahead in understanding the Bone Metastasis Treatment Landscape. Click here to read more @ Bone Metastasis Pipeline Outlook- https://www.delveinsight.com/sample-request/bone-metastasis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Bone Metastasis Pipeline Report
• In June 2025, Shenyang Sunshine Pharmaceutical Co. Ltd announced a Phase Ib/IIa, multicenter, sequential clinical trial evaluating the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of SSS40 injection in patients with moderate-to-severe bone metastatic cancer pain. The study includes two stages: a single-arm, open-label, dose-escalation and dose-expansion Phase Ib followed by a randomized, double-blind, placebo-controlled Phase IIa.
• DelveInsight's Bone Metastasis pipeline report depicts a robust space with 10+ active players working to develop 10+ pipeline therapies for Bone Metastasis treatment.
• The leading Bone Metastasis Companies such as Mabwell (Shanghai) Bioscience Co., Ltd., AlaMab Therapeutics, Qilu Pharmaceutical Co., Ltd., Exelixis, Shanghai JMT-Bio Inc., BiologicsMD, Luye Pharma Group Ltd., QSAM Biosciences Inc., Serene, LLC, Isotopen Technologien Munchens and others.
• Promising Bone Metastasis Pipeline Therapies such as Radium Ra 223 Dichloride, MW032, Xgeva, Zoledronic Acid, Radium-223 chloride (BAY88-8223), Pamidronate, Docetaxel and others.
Discover groundbreaking developments in Bone Metastasis Therapies! Gain in-depth knowledge of key Bone Metastasis clinical trials, emerging drugs, and market opportunities @ Bone Metastasis Clinical Trials Assessment- https://www.delveinsight.com/sample-request/bone-metastasis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Bone Metastasis Emerging Drugs Profile
• MW032: Mabwell (Shanghai) Bioscience Co., Ltd.
MW032 is a Denosumab biosimilar being developed by Mabwell (Shanghai) Bioscience Co., Ltd. Denosumab is a fully human monoclonal antibody that binds the cytokine RANKL (receptor activator of NFκB ligand), an essential factor initiating bone turnover. RANKL inhibition blocks osteoclast maturation, function and survival, thus reducing bone resorption. MW032 is currently in Phase III stage of development to treat Bone Metastases from Solid Tumors.
• ALMB-0168: AlaMab Therapeutics
ALMB-0168 is a first-inclass humanized monoclonal antibody agonist for hemichannel Cx43 membrane protein. Through the activation of Cx43 protein to release tumor-inhibiting cytokines, ALMB-0168 has shown to effectively inhibit osteosarcoma and bone metastasis in pre-clinical in vitro and in vivo animal studies. ALMB-0168 has received Orphan Disease Drug and Rare Pediatric Disease designations from the FDA for its use in osteosarcoma.
The Bone Metastasis Pipeline Report Provides Insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Bone Metastasis with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Bone Metastasis Treatment.
• Bone Metastasis Companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Bone Metastasis Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Bone Metastasis market
Stay informed about the Bone Metastasis pipeline trends! Uncover critical updates on therapeutic innovations and their potential impact on patients and the healthcare industry @ Bone Metastasis Unmet Needs- https://www.delveinsight.com/sample-request/bone-metastasis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Bone Metastasis Companies
Mabwell (Shanghai) Bioscience Co., Ltd., AlaMab Therapeutics, Qilu Pharmaceutical Co., Ltd., Exelixis, Shanghai JMT-Bio Inc., BiologicsMD, Luye Pharma Group Ltd., QSAM Biosciences Inc., Serene, LLC, Isotopen Technologien Munchens and others.
Bone Metastases Pipeline Report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Inhalation
• Inhalation/Intravenous/Oral
• Intranasal
• Intravenous
• Intravenous/ Subcutaneous
• NA
• Oral
• Oral/intranasal/subcutaneous
• Parenteral
• Subcutaneous
Bone Metastasis Products have been categorized under various Molecule types such as
• Antibody
• Antisense oligonucleotides
• Immunotherapy
• Monoclonal antibody
• Peptides
• Protein
• Recombinant protein
• Small molecule
• Stem Cell
• Vaccine
Transform your understanding of the Bone Metastasis Pipeline! See the latest progress in drug development and clinical research @ Bone Metastasis Market Drivers and Barriers, and Future Perspectives- https://www.delveinsight.com/sample-request/bone-metastasis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Bone Metastasis Pipeline Report
• Coverage- Global
• Bone Metastasis Companies- Mabwell (Shanghai) Bioscience Co., Ltd., AlaMab Therapeutics, Qilu Pharmaceutical Co., Ltd., Exelixis, Shanghai JMT-Bio Inc., BiologicsMD, Luye Pharma Group Ltd., QSAM Biosciences Inc., Serene, LLC, Isotopen Technologien Munchens and others.
• Bone Metastasis Pipeline Therapies- Radium Ra 223 Dichloride, MW032, Xgeva, Zoledronic Acid, Radium-223 chloride (BAY88-8223), Pamidronate, Docetaxel and others.
• Bone Metastasis Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Bone Metastasis Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
Stay Ahead in Research-Access the Full Bone Metastasis Pipeline Analysis Today! @ Bone Metastasis Drugs and Companies- https://www.delveinsight.com/sample-request/bone-metastasis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight here
News-ID: 4155136 • Views: …
More Releases from DelveInsight Business Research LLP
Opioid Withdrawal Syndrome Market Size in the 7MM was valued ~USD 1,302 million …
DelveInsight's "Opioid Withdrawal Syndrome Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Opioid Withdrawal Syndrome, historical and forecasted epidemiology and the Opioid Withdrawal Syndrome market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
Download DelveInsight's comprehensive report to explore market trends, pipeline analysis, and emerging therapies @ Opioid Withdrawal Syndrome Market Size- https://www.delveinsight.com/sample-request/opioid-withdrawal-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
…
Netherton Syndrome Treatment Market Size in the 7MM was valued at ~USD 25 millio …
DelveInsight's "Netherton Syndrome Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Netherton Syndrome, historical and forecasted epidemiology as well as the Netherton Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
Unlock key insights into the Netherton Syndrome Market! Download DelveInsight's comprehensive report to explore market trends, pipeline analysis, and emerging therapies @ Netherton Syndrome Market Size-…
Nephrotic Syndrome Treatment Market Size in the 7MM reached ~USD 401 million in …
DelveInsight's "Nephrotic Syndrome Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Nephrotic Syndrome, historical and forecasted epidemiology, and the Nephrotic Syndrome market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
Unlock key insights into the Nephrotic Syndrome Market! Download DelveInsight's comprehensive report to explore market trends, pipeline analysis, and emerging therapies @ Nephrotic Syndrome Market Size-…
Leptomeningeal Metastases Market Size in 7MM was ~USD 1700 Million in 2024 and w …
DelveInsight's " Leptomeningeal Metastases Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of Leptomeningeal Metastases, historical and forecasted epidemiology, as well as the Leptomeningeal Metastases Market Trends in the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan.
Discover Key Insights into the Leptomeningeal Metastases Market with DelveInsight's In-Depth Report @ Leptomeningeal Metastases Treatment Market Size- https://www.delveinsight.com/sample-request/leptomeningeal-metastases-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Leptomeningeal…
More Releases for Bone
Bone Densitometers (BDM): Precise Assessment of Bone Health and Osteoporosis Ris …
Bone Densitometers(BDM) Market 2023 Forecast: Unveiling Opportunities and Growth
Bone Densitometers(BDM) Market research report helps to recognize the market challenges and opportunities. Global Bone Densitometers(BDM) Market report contains the recent forecast research for the predicted period. The report extensively offers the latest information about the technological developments and market growth prospect on the basis of the regional landscape. This Report offers a complete evaluation of every area including the volume of…
Demineralized Bone Matrix Market - A Natural Approach to Bone Repair: Deminerali …
Newark, New Castle, USA: The "Demineralized Bone Matrix Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Demineralized Bone Matrix Market: https://www.growthplusreports.com/report/demineralized-bone-matrix-market/7805
This latest report researches the industry structure,…
Bone Glue Market: Rising Adoption of Bone Glue for Orthopedic Surgeries Expected …
The Bone Glue Market is a rapidly growing segment of the medical industry, driven by the increasing prevalence of bone fractures and injuries and the rising demand for effective and reliable bone adhesives. Bone glue, also known as surgical adhesive, is a type of medical adhesive that is used to bond bones together during orthopedic surgeries. The market has been growing steadily for several years, and it is expected to…
Bone Glue Market: Rising Adoption of Bone Glue for Orthopedic Surgeries Expected …
The Bone Glue Market is a rapidly growing segment of the medical industry, driven by the increasing prevalence of bone fractures and injuries and the rising demand for effective and reliable bone adhesives. Bone glue, also known as surgical adhesive, is a type of medical adhesive that is used to bond bones together during orthopedic surgeries. The market has been growing steadily for several years, and it is expected to…
Bone Glue Market: Rising Adoption of Bone Glue for Orthopedic Surgeries Expected …
The Bone Glue Market is a rapidly growing segment of the medical industry, driven by the increasing prevalence of bone fractures and injuries and the rising demand for effective and reliable bone adhesives. Bone glue, also known as surgical adhesive, is a type of medical adhesive that is used to bond bones together during orthopedic surgeries. The market has been growing steadily for several years, and it is expected to…
Bone Graft Substitute Market Report 2018: Segmentation by Type (autograft, demin …
Global Bone Graft Substitute market research report provides company profile for ACE Surgical Supply Company, Inc., BioHorizons IPH, Inc., Dentium Co., Ltd., Dentsply Sirona, Institut Straumann AG, Medtronic plc, Stryker Corporation, Zimmer Biomet and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and…
